Medical Countermeasures Are an FDA Priority, Gottlieb Tells Lawmakers

Drug Industry Daily
A A
Enabling access to medical countermeasures for material threats is a top FDA priority, according to Commissioner Scott Gottlieb, who reviewed the agency’s efforts before a Senate committee Wednesday.

To View This Article:

Login

Subscribe To Drug Industry Daily